The global next-generation sequencing services market size is expected to reach USD 24.48 billion by 2030, according to the report. It is expected to expand at a CAGR of 22.68% from 2024 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users. ![Global Next-generation Sequencing Services Market]( "Global Next-generation Sequencing Services Market")
Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.
With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.
Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.
With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.
Next-generation Sequencing Services Market Report Highlights
- By service type, human genome sequencing held the largest revenue share in 2023 owing to greater penetration of whole genome and whole exome sequencing
- Gene regulation services, particularly small RNA sequencing and ChIP-seq, are anticipated to grow at a lucrative pace during the forecast period. Rising investment in RNA sequencing is fueling the growth of gene regulation services
- The larger revenue share of sequencing services as compared to other workflow steps can be attributed to an increase in the installation of sequencing platforms. High maintenance and recovery costs of this step have also resulted in greater revenue generation
- By end-use, the universities and other research entities segment held the largest revenue share in 2023 owing to the growing application of NGS technology for cancer prognosis as well as diagnosis and major projects taken up by academicians and universities
- North America dominated the market in 2023 owing to higher penetration of the technology in this region and the availability of funds to employ the technique and derive research findings for disease targeting
- Companies such as GENEWIZ and Novogene Corporation are engaged in offering NGS services based on platforms from major NGS developers. Companies such as Illumina and BGI, on the other hand, are involved in developing sequencing instruments and offering services to research entities
- In November 2021, Novogene stated during the 44th Annual Gathering of Molecular Biological Society of Japan (MSBJ) in Japan that they will be launching single-cell sequencing services specifically for their Japanese customers
- GENEWIZ scientists are assisting in identifying the NGS solution for the projects. The NeXT Dx Test was launched by Personalis, Inc. to assist oncologists in identifying new therapy and clinical trial choices for cancer patients
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Information Procurement
1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
1.7.1. Objective 1
1.7.2. Objective 2
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Information Procurement
1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
1.7.1. Objective 1
1.7.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Decline in sequencing prices
3.3.2. Growing awareness pertaining to women & reproductive health
3.3.3. Strategies undertaken for implementation of clinical NGS
3.4. Market Restraint Analysis
3.4.1. Challenges pertaining to implementation of large-scale NGS analysis workflows
3.4.2. Analytical challenges in single cell sequencing
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Decline in sequencing prices
3.3.2. Growing awareness pertaining to women & reproductive health
3.3.3. Strategies undertaken for implementation of clinical NGS
3.4. Market Restraint Analysis
3.4.1. Challenges pertaining to implementation of large-scale NGS analysis workflows
3.4.2. Analytical challenges in single cell sequencing
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Service Type Business Analysis
4.1. Global Next Generation Sequencing Services Market: Service Type Movement Analysis
4.2. Human Genome Sequencing Services
4.2.1. Human Genome Sequencing Services Market, 2018 - 2030 (USD Million)
4.3. Single-Cell Sequencing Services
4.3.1. Single-Cell Sequencing Services Market, 2018 - 2030 (USD Million)
4.4. Microbial Genome-based Sequencing Services
4.4.1. Microbial Genome-based Sequencing Services Market, 2018 - 2030 (USD Million)
4.5. Gene Regulation Services
4.5.1. Gene Regulation Services Market, 2018 - 2030 (USD Million)
4.5.2. Small RNA Sequencing Services
4.5.2.1. Small RNA Sequencing Services Market, 2018 - 2030 (USD Million)
4.5.3. Chip Sequencing Services
4.5.3.1. Chip Sequencing Services Market, 2018 - 2030 (USD Million)
4.5.4. Other Gene Regulation-based Service
4.5.4.1. Other Gene Regulation-based Service Market, 2018 - 2030 (USD Million)
4.6. Animal & Plant Sequencing Services
4.6.1. Animal & Plant Sequencing Services Market, 2018 - 2030 (USD Million)
4.7. Other Sequencing Services
4.7.1. Other Sequencing Services Market, 2018 - 2030 (USD Million)
4.2. Human Genome Sequencing Services
4.2.1. Human Genome Sequencing Services Market, 2018 - 2030 (USD Million)
4.3. Single-Cell Sequencing Services
4.3.1. Single-Cell Sequencing Services Market, 2018 - 2030 (USD Million)
4.4. Microbial Genome-based Sequencing Services
4.4.1. Microbial Genome-based Sequencing Services Market, 2018 - 2030 (USD Million)
4.5. Gene Regulation Services
4.5.1. Gene Regulation Services Market, 2018 - 2030 (USD Million)
4.5.2. Small RNA Sequencing Services
4.5.2.1. Small RNA Sequencing Services Market, 2018 - 2030 (USD Million)
4.5.3. Chip Sequencing Services
4.5.3.1. Chip Sequencing Services Market, 2018 - 2030 (USD Million)
4.5.4. Other Gene Regulation-based Service
4.5.4.1. Other Gene Regulation-based Service Market, 2018 - 2030 (USD Million)
4.6. Animal & Plant Sequencing Services
4.6.1. Animal & Plant Sequencing Services Market, 2018 - 2030 (USD Million)
4.7. Other Sequencing Services
4.7.1. Other Sequencing Services Market, 2018 - 2030 (USD Million)
Chapter 5. Workflow Business Analysis
5.1. Global Next Generation Sequencing Services market: Workflow Movement Analysis
5.2. Pre Sequencing Service
5.2.1. Pre Sequencing Service Market, 2018 - 2030 (USD Million)
5.3. Sequencing Service
5.3.1. Sequencing Service Market, 2018 - 2030 (USD Million)
5.4. Data Analysis Service
5.4.1. Data Analysis Service Market, 2018 - 2030 (USD Million)
5.2. Pre Sequencing Service
5.2.1. Pre Sequencing Service Market, 2018 - 2030 (USD Million)
5.3. Sequencing Service
5.3.1. Sequencing Service Market, 2018 - 2030 (USD Million)
5.4. Data Analysis Service
5.4.1. Data Analysis Service Market, 2018 - 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Global Next Generation Sequencing Services Market: End-use Movement Analysis
6.2. Universities & Other Research Entities
6.2.1. Universities & Other Research Entities Market, 2018 - 2030 (USD Million)
6.3. Hospitals & Clinics
6.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
6.4. Pharma & Biotech Entities
6.4.1. Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
6.2. Universities & Other Research Entities
6.2.1. Universities & Other Research Entities Market, 2018 - 2030 (USD Million)
6.3. Hospitals & Clinics
6.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
6.4. Pharma & Biotech Entities
6.4.1. Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Global Next generation sequencing services market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Next generation sequencing services market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. Next generation sequencing services market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. Germany Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. UK Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. France Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. Italy Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Spain Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.10. Switzerland
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Scenario
7.3.10.3. Regulatory Framework
7.3.10.4. Target Disease Prevalence
7.3.10.5. Switzerland Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Australia Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Thailand Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.8. Singapore
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Target Disease Prevalence
7.4.8.5. Singapore Next generation sequencing services market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Next generation sequencing services market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil Next generation sequencing services market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Mexico Next generation sequencing services market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Target Disease Prevalence
7.5.4.5. Argentina Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait Next generation sequencing services market, 2018 - 2030 (USD Million)
7.2. North America
7.2.1. North America Next generation sequencing services market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. Next generation sequencing services market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. Germany Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. UK Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. France Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. Italy Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Spain Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway Next generation sequencing services market, 2018 - 2030 (USD Million)
7.3.10. Switzerland
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Scenario
7.3.10.3. Regulatory Framework
7.3.10.4. Target Disease Prevalence
7.3.10.5. Switzerland Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Australia Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Thailand Next generation sequencing services market, 2018 - 2030 (USD Million)
7.4.8. Singapore
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Target Disease Prevalence
7.4.8.5. Singapore Next generation sequencing services market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Next generation sequencing services market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil Next generation sequencing services market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Mexico Next generation sequencing services market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Target Disease Prevalence
7.5.4.5. Argentina Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE Next generation sequencing services market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait Next generation sequencing services market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market/Position Share Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Quest Diagnostics Incorporated
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. ARUP Laboratories
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Applied Biological Materials, Inc. (abm)
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Novogene Co, Ltd.
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Azenta Life Sciences (GENEWIZ)
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. NanoString
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Illumina, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. PacBio
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Veritas
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. BGI (Beijing Genomics Institute)
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Gene by Gene Ltd.
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Lucigen Corporation
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.2. Strategy Mapping
8.3. Company Market/Position Share Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Quest Diagnostics Incorporated
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. ARUP Laboratories
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Applied Biological Materials, Inc. (abm)
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Novogene Co, Ltd.
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Azenta Life Sciences (GENEWIZ)
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. NanoString
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Illumina, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. PacBio
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Veritas
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. BGI (Beijing Genomics Institute)
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Gene by Gene Ltd.
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Lucigen Corporation
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global next generation sequencing services market by service type, 2018 - 2030 (USD Million)
Table 4 Global next generation sequencing services market by workflow, 2018 - 2030 (USD Million)
Table 5 Global next generation sequencing services market by end-use, 2018 - 2030 (USD Million)
Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 8 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 15 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 16 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 17 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 20 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 21 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 22 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 24 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 25 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 26 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 27 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 28 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 29 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 30 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 31 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 32 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 33 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 34 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 36 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 37 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 38 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 39 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 40 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 41 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 42 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 43 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 44 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 45 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 49 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 51 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 52 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 53 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 54 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 55 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 56 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 57 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 58 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 59 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 60 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 61 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 62 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 63 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 64 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 65 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 66 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 67 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 68 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 69 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 70 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 71 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 72 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 73 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 74 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 75 Latin America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 76 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 77 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 78 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 79 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 80 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 81 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 87 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 97 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 101 Participant’s Overview
Table 102 Financial Performance
Table 103 Key Companies Undergoing Expansions
Table 104 Key Companies Undergoing Acquisitions
Table 105 Key Companies Undergoing Collaborations
Table 106 Key Companies Launching New Products/Services
Table 107 Key Companies Undergoing Partnerships
Table 108 Key Companies Undertaking Other Strategies
Table 2 List Of Abbreviations
Table 3 Global next generation sequencing services market by service type, 2018 - 2030 (USD Million)
Table 4 Global next generation sequencing services market by workflow, 2018 - 2030 (USD Million)
Table 5 Global next generation sequencing services market by end-use, 2018 - 2030 (USD Million)
Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 8 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 15 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 16 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 17 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 20 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 21 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 22 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 24 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 25 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 26 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 27 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 28 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 29 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 30 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 31 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 32 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 33 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 34 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 36 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 37 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 38 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 39 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 40 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 41 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 42 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 43 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 44 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 45 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 49 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 51 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 52 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 53 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 54 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 55 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 56 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 57 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 58 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 59 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 60 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 61 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 62 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 63 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 64 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 65 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 66 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 67 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 68 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 69 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 70 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 71 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 72 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 73 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 74 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 75 Latin America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 76 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 77 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 78 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 79 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 80 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 81 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 87 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 97 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 101 Participant’s Overview
Table 102 Financial Performance
Table 103 Key Companies Undergoing Expansions
Table 104 Key Companies Undergoing Acquisitions
Table 105 Key Companies Undergoing Collaborations
Table 106 Key Companies Launching New Products/Services
Table 107 Key Companies Undergoing Partnerships
Table 108 Key Companies Undertaking Other Strategies
List of Figures
Fig. 1 Market Others process
Fig. 2 Data triangulation techniques
Fig. 3 Primary Others pattern
Fig. 4 Market Others approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2023 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 Next-generation sequencing services market: Service type outlook and key takeaways
Fig. 16 Next-generation sequencing services market: Service type movement analysis
Fig. 17 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Single-cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Small RNA sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Chip sequencing service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Other gene regulation-based service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Next-generation sequencing services market: Workflow outlook and key takeaways
Fig. 27 Next generation sequencing services market: Workflow movement analysis
Fig. 28 Pre sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Data analysis service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Next-generation sequencing services market: End-use outlook and key takeaways
Fig. 32 Next-generation sequencing services market: End-use movement analysis
Fig. 33 Universities & other research entities, 2018 - 2030 (USD Million)
Fig. 34 Hospitals & clinics, 2018 - 2030 (USD Million)
Fig. 35 Pharma & biotech entities, 2018 - 2030 (USD Million)
Fig. 36 Other end-use, 2018 - 2030 (USD Million)
Fig. 37 Global next generation sequencing services market: Regional outlook and key takeaways
Fig. 38 North America next generation sequencing services market, 2018 - 2030 (USD million)
Fig. 39 US key country dynamics
Fig. 40 US next generation sequencing services market, 2018 - 2030 (USD million)
Fig. 41 Canada key country dynamics
Fig. 42 Canada next generation sequencing services market, 2018 - 2030 (USD million)
Fig. 43 Europe next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 44 Germany key country dynamics
Fig. 45 Germany next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 46 France key country dynamics
Fig. 47 France next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 48 UK key country dynamics
Fig. 49 UK next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 50 Italy key country dynamics
Fig. 51 Italy next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 52 Spain key country dynamics
Fig. 53 Spain next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 54 Denmark key country dynamics
Fig. 55 Denmark next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 56 Sweden key country dynamics
Fig. 57 Sweden next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 58 Norway key country dynamics
Fig. 59 Norway next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 60 Switzerland key country dynamics
Fig. 61 Switzerland next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 62 Asia-Pacific next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 63 China key country dynamics
Fig. 64 China next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 65 India key country dynamics
Fig. 66 India next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 67 South Korea key country dynamics
Fig. 68 South Korea next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 69 Japan key country dynamics
Fig. 70 Japan next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 71 Australia key country dynamics
Fig. 72 Australia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 73 Thailand key country dynamics
Fig. 74 Thailand next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 75 Singapore key country dynamics
Fig. 76 Singopore next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 77 Latin America next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 78 Brazil key country dynamics
Fig. 79 Brazil next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 80 Mexico key country dynamics
Fig. 81 Mexico next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 82 Argentina key country dynamics
Fig. 83 Argentina next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 84 MEA next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 85 South Africa key country dynamics
Fig. 86 South Africa next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 87 Saudi Arabia key country dynamics
Fig. 88 Saudi Arabia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 89 UAE key country dynamics
Fig. 90 UAE next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 91 Kuwait key country dynamics
Fig. 92 Kuwait next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 93 Market participant categorization
Fig. 94 Next generation sequencing services market share analysis, 2023
Fig. 95 Strategy framework
Fig. 2 Data triangulation techniques
Fig. 3 Primary Others pattern
Fig. 4 Market Others approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2023 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 Next-generation sequencing services market: Service type outlook and key takeaways
Fig. 16 Next-generation sequencing services market: Service type movement analysis
Fig. 17 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Single-cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Small RNA sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Chip sequencing service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Other gene regulation-based service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Next-generation sequencing services market: Workflow outlook and key takeaways
Fig. 27 Next generation sequencing services market: Workflow movement analysis
Fig. 28 Pre sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Data analysis service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Next-generation sequencing services market: End-use outlook and key takeaways
Fig. 32 Next-generation sequencing services market: End-use movement analysis
Fig. 33 Universities & other research entities, 2018 - 2030 (USD Million)
Fig. 34 Hospitals & clinics, 2018 - 2030 (USD Million)
Fig. 35 Pharma & biotech entities, 2018 - 2030 (USD Million)
Fig. 36 Other end-use, 2018 - 2030 (USD Million)
Fig. 37 Global next generation sequencing services market: Regional outlook and key takeaways
Fig. 38 North America next generation sequencing services market, 2018 - 2030 (USD million)
Fig. 39 US key country dynamics
Fig. 40 US next generation sequencing services market, 2018 - 2030 (USD million)
Fig. 41 Canada key country dynamics
Fig. 42 Canada next generation sequencing services market, 2018 - 2030 (USD million)
Fig. 43 Europe next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 44 Germany key country dynamics
Fig. 45 Germany next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 46 France key country dynamics
Fig. 47 France next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 48 UK key country dynamics
Fig. 49 UK next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 50 Italy key country dynamics
Fig. 51 Italy next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 52 Spain key country dynamics
Fig. 53 Spain next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 54 Denmark key country dynamics
Fig. 55 Denmark next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 56 Sweden key country dynamics
Fig. 57 Sweden next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 58 Norway key country dynamics
Fig. 59 Norway next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 60 Switzerland key country dynamics
Fig. 61 Switzerland next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 62 Asia-Pacific next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 63 China key country dynamics
Fig. 64 China next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 65 India key country dynamics
Fig. 66 India next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 67 South Korea key country dynamics
Fig. 68 South Korea next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 69 Japan key country dynamics
Fig. 70 Japan next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 71 Australia key country dynamics
Fig. 72 Australia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 73 Thailand key country dynamics
Fig. 74 Thailand next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 75 Singapore key country dynamics
Fig. 76 Singopore next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 77 Latin America next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 78 Brazil key country dynamics
Fig. 79 Brazil next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 80 Mexico key country dynamics
Fig. 81 Mexico next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 82 Argentina key country dynamics
Fig. 83 Argentina next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 84 MEA next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 85 South Africa key country dynamics
Fig. 86 South Africa next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 87 Saudi Arabia key country dynamics
Fig. 88 Saudi Arabia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 89 UAE key country dynamics
Fig. 90 UAE next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 91 Kuwait key country dynamics
Fig. 92 Kuwait next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
Fig. 93 Market participant categorization
Fig. 94 Next generation sequencing services market share analysis, 2023
Fig. 95 Strategy framework
Companies Profiled
- QUEST DIAGNOSTICS INCORPORATED
- ARUP LABORATORIES
- APPLIED BIOLOGICAL MATERIALS, INC. (ABM)
- NOVOGENE CO, LTD.
- AZENTA LIFE SCIENCES (GENEWIZ)
- NANOSTRING
- ILLUMINA, INC.
- PACBIO
- VERITAS
- BGI (BEIJING GENOMICS INSTITUTE)
- GENE BY GENE LTD.
- LUCIGEN CORPORATION
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | November 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 5.89 Billion |
| Forecasted Market Value ( USD | $ 24.48 Billion |
| Compound Annual Growth Rate | 22.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
